With Disruptive, Vapor-Based Endoscopic Ablation Therapy
Aqua Medical’s unique ablation technology consists of high-temperature, high-energy water vapor created by a radio frequency generator and delivered through an endoscope. It is a true platform technology in that a single RF-vapor generator system with two unique catheters can deliver treatment for multiple diseases throughout the GI tract.
Radiofrequency Vapor Ablation of Duodenal Mucosa
Non-surgical through-the-endoscope ablation of duodenal mucosa, intended as a treatment to improve glycemic control in patients with Type 2 Diabetes, a disease of epidemic proportions.
Non-surgical through-the-endoscope ablation of precancerous Barrett’s tissue, intended to prevent its progression to esophageal cancer, one of the fastest rising cancers in the US.
Non-surgical through-the-endoscope ablation of precancerous pancreatic cysts, designed to prevent its progression toward pancreatic cancer, one of the most lethal cancers in the US.
Our through-the-endoscope duodenal mucosal ablation technology can benefit patients with metabolic conditions, including Type-2 DM. Our platform is designed to deliver a simple, through-the-endoscope procedure with better speed and ease-of-use, and more uniform mucosal ablation.
Endoscopic ablative therapy is the standard of care for the treatment of dysplastic and select non-dysplastic Barrett’s esophagus. Aqua Medical’s FDA cleared platform is intended to be simpler, faster, safer, and easier to use compared to current therapies for treatment of Barrett’s esophagus.
For the precancerous pancreatic cyst market, Aqua will offer the first effective endoscopic therapy to treat pancreatic cysts and to prevent potential progression to pancreatic cancer, without the need for pancreatic surgery.